Geron Corporation (GERN)
Healthcare
Biotechnology
1.30 $
-3.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Geron Corporation (GERN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -63 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -30 | -51 | -41 | -62 | -53 | -59 | -44 | -48 | -27 | -14 | -22 | -63 | -126 | |
| 0.3 | 0.3 | 0.2 | 0.3 | 0.4 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 1.2 | |
| 4.0 | 7.6 | 4.6 | 5.0 | 13 | 6.9 | 6.8 | 7.4 | -7.4 | 6.8 | 7.4 | 4.9 | 12 | |
| 0.8 | 4.3 | – | – | – | – | – | – | – | – | – | – | – | |
| 18 | -11 | 8.7 | -11 | 2.7 | -38 | -23 | -35 | -19 | -2.3 | -12 | -64 | -97 | |
| 0.2 | 0.2 | 0.1 | 0.6 | 0.2 | 0.0 | 0.1 | 48 | 0.1 | 0.1 | 0.0 | 0.3 | 0.5 | |
| -44 | -4.7 | 48 | 34 | -36 | -0.6 | -104 | 52 | 20 | 13 | 21 | 52 | 107 | |
| 18 | 29 | 33 | 148 | 17 | 3.6 | 166 | 0.3 | 1.1 | 0.5 | 0.4 | 2.4 | 4.4 | |
| -56 | -26 | 40 | 120 | -73 | -56 | 19 | 4.7 | -6.0 | 0.4 | -0.6 | -8.7 | -15 | |
| -30 | -51 | -41 | -63 | -54 | -59 | -44 | -48 | -28 | -13 | -22 | -63 | -126 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.